Acute respiratory viral infection in children: an open dialogue live. Resolution of the International Expert Council December 8, 2024 Moscow
- Authors: Zakharova I.N.1, Gorelov A.V.2,3, Geppe N.A.3, Sabitov A.U.4, Abdrakhmanova S.T.5, Sulaimanov S.A.6, Petlenko S.V.7,8, Afanasieva O.I.9, Ilyenkova N.A.10, Pervishko O.V.11
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- Central Research Institute of Epidemiology
- Sechenov First Moscow State Medical University (Sechenov University)
- Ural State Medical University
- Astana Medical University
- National Center for Maternal and Child Health
- Golikov Scientific and Clinical Center of Toxicology
- Medical and Biological Scientific and Production Complex “Cytomed” LLC
- Smorodintsev Research Institute of Influenza
- Voino-Yasenetsky Krasnoyarsk State Medical University
- Kuban State Medical University
- Issue: No 1 (2025)
- Pages: 74-79
- Section: Articles
- URL: https://pediatria.orscience.ru/2658-6630/article/view/678104
- DOI: https://doi.org/10.26442/26586630.2025.1.203128
- ID: 678104
Cite item
Full Text
Abstract
On December 8, 2024, the International Council of Experts was held in Moscow to discuss methods of prevention and comprehensive therapy of respiratory infectious diseases in children, including those with chronic diseases. The experts presented reports on several topical issues: the current epidemic situation of acute respiratory viral infections (ARVI) and influenza, the problem of prevention and treatment of influenza and ARVI in children, including those with allergic conditions, chronic hepatitis, and the peculiarities of the effect of respiratory viruses on immunity in children. The paper focused on the evidence base, efficacy, and safety of Cytovir-3, a drug for the prevention, etiotropic, and immunostimulating therapy of influenza and ARVI.
Full Text

About the authors
Irina N. Zakharova
Russian Medical Academy of Continuous Professional Education
Author for correspondence.
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0003-4200-4598
D. Sci. (Med.), Prof
Russian Federation, Moscow
Aleksandr V. Gorelov
Central Research Institute of Epidemiology; Sechenov First Moscow State Medical University (Sechenov University)
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0001-9257-0171
D. Sci. (Med.), Prof., Acad. RAS, Central Research Institute of Epidemiology
Russian Federation, Moscow; MoscowNatalia A. Geppe
Sechenov First Moscow State Medical University (Sechenov University)
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0003-0547-3686
D. Sci. (Med.), Prof.
Russian Federation, MoscowAlebai U. Sabitov
Ural State Medical University
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0003-0858-9529
D. Sci. (Med.), Prof.
Russian Federation, EkaterinburgSagira T. Abdrakhmanova
Astana Medical University
Email: zakharova-rmapo@yandex.ru
D. Sci. (Med.), Prof., Astana Medical University
Kazakhstan, AstanaShaiirbek A. Sulaimanov
National Center for Maternal and Child Health
Email: zakharova-rmapo@yandex.ru
D. Sci. (Med.), Prof.
Kazakhstan, BishkekSergey V. Petlenko
Golikov Scientific and Clinical Center of Toxicology; Medical and Biological Scientific and Production Complex “Cytomed” LLC
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0002-2752-4598
D. Sci. (Med.), Prof.
Russian Federation, Saint Petersburg; Saint PetersburgOlga I. Afanasieva
Smorodintsev Research Institute of Influenza
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0002-1229-171X
D. Sci. (Med.), Smorodintsev Research Institute of Influenza
Russian Federation, Saint PetersburgNatalya A. Ilyenkova
Voino-Yasenetsky Krasnoyarsk State Medical University
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0001-8058-7806
D. Sci. (Med.), Prof.
Russian Federation, KrasnoyarskOlesia V. Pervishko
Kuban State Medical University
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0003-1083-2807
Cand. Sci. (Med.), Assoc. Prof.
Russian Federation, KrasnodarReferences
- Maison N, Omony J, Rinderknecht S, et al. Old foes following news ways? – Pandemic-related changes in the epidemiology of viral respiratory tract infections. Infection. 2023;52(1):209-18. doi: 10.1007/s15010-023-02085-w
- Здравоохранение в России. Статистический сборник. М. 2019 [Zdravookhranenie v Rossii. Statisticheskii sbornik. Moscow. 2019 (in Russian)].
- Геппе Н.А., Горелов А.В., Козлова Л.В., и др. Острые инфекции дыхательных путей у детей. Диагностика, лечение и профилактика. Клиническое руководство. М.: МедКомПро, 2020 [Geppe NA, Gorelov AV, Kozlova LV, et al. Ostrye infektsii dykhatel'nykh putei u detei. Diagnostika, lechenie i profilaktika. Klinicheskoe rukovodstvo. Moscow: MedKomPro, 2020 (in Russian)].
- Калюжин О.В. Острые респираторные вирусные инфекции: современные вызовы, противовирусный ответ, иммунопрофилактика и иммунотерапия. М.: МИА, 2014 [Kaliuzhin OV. Ostrye respiratornye virusnye infektsii: sovremennye vyzovy, protivovirusnyi otvet, immunoprofilaktika i immunoterapiia. Moscow: MIA, 2014 (in Russian)].
- Pathogens prioritization: a scientific framework for epidemic and pandemic research preparedness. Available at: https://www.who.int/publications/m/item/pathogens-prioritization-a-scientific-framework-for-epidemic-and-pandemic-research-preparedness. Accessed: 06.12.2024.
- van Doorn HR, Yu H. Viral Respiratory Infections. Hunt Trop Med Emerg Infect Dis. 2020;284-8. doi: 10.1016/B978-0-323-55512-8.00033-8
- Мигачева Н.Б., Каганова Т.И., Аронова А.В. Особенности течения острых респираторных инфекций у детей с аллергическими болезнями: проблемы ведения пациентов и пути их решения. Вопросы современной педиатрии. 2013;12(2):78-84 [Migacheva NB, Kaganova TI, Aronova AV. Special Features of Acute Respiratory Infections Clinical Course in Children with Allergic Disorders: Problems of Management and Ways to Solve Them. Voprosy sovremennoi pediatrii – Current Pediatrics. 2013;12(2):78-84 (in Russian)].
- Khanna NR, Gerriets V. Interferon. StatPearls. Treasure Island (FL): StatPearls Publishing, 2024.
- Dalskov L, Gad HH, Hartmann R. Viral recognition and the antiviral interferon response. EMBO J. 2023;42(14):e112907. doi: 10.15252/embj.2022112907
- Pecora F, Persico F, Argentiero A, et al. The Role of Micronutrients in Support of the Immune Response against Viral Infections. Nutrients. 2020;12(10):3198. doi: 10.3390/nu12103198
- Острая респираторная вирусная инфекция (ОРВИ). Дети. Клинические рекомендации 2022 г. [Ostraia respiratornaia virusnaia infektsiia (ORVI). Deti. Klinicheskie rekomendatsii 2022 g. (in Russian)].
- Государственный реестр лекарственных средств. Регистрационное удостоверение лекарственного препарата Ксофлюза®, МНН балоксавир марбоксил ЛП-№(000927)-(РГ-RU). Режим доступа: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=b618ec0b-2bd6-4562-b95d-a83148ee36c8. Ссылка активна на 07.12.2024 [Gosudarstvennyi reestr lekarstvennykh sredstv. Registratsionnoe udostoverenie lekarstvennogo preparata Ksofliuza®, MNN baloksavir marboksil LP-№(000927)-(RG-RU). Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=b618ec0b-2bd6-4562-b95d-a83148ee36c8. Accessed: 07.12.2024 (in Russian)].
- Государственный реестр лекарственных средств. Регистрационные свидетельства на лекарственные препараты с умифеновиром (МНН). Режим доступа: https://grls.rosminzdrav.ru/GRLS.aspx?isfs=0®type=1%2c6&pageSize=10&order=Registered&orderType=desc&pageNum=1&MnnR=%D0%A3%D0%BC%D0%B8%D1%84%D0%B5%D0%BD%D0%BE%D0%B2%D0%B8%D1%80&token=88356e54-a1ce-4af0-9ccc-955629468528. Ссылка активна на 07.12.2024 [Gosudarstvennyi reestr lekarstvennykh sredstv. Registratsionnye svidetel'stva na lekarstvennye preparaty s umifenovirom (MNN). Available at: https://grls.rosminzdrav.ru/GRLS.aspx?isfs=0®type=1%2c6&pageSize=10&order=Registered&orderType=desc&pageNum=1&MnnR=%D0%A3%D0%BC%D0%B8%D1%84%D0%B5%D0%BD%D0%BE%D0%B2%D0%B8%D1%80&token=88356e54-a1ce-4af0-9ccc-955629468528. Accessed: 07.12.2024 (in Russian)].
- Смирнов В.С., Зарубаев В.В., Петленко С.В. Биология возбудителей и контроль гриппа и ОРВИ. СПб.: Гиппократ, 2020 [Smirnov VS, Zarubaev VV, Petlenko SV. Biologiia vozbuditelei i kontrol' grippa i ORVI. Saint Petersburg: Gippokrat, 2020 (in Russian)].
- Соколова Т.М., Полосков В.В., Шувалов А.Н., и др. Сигнальные TLR/RLR-механизмы иммуно-модулирующего действия препаратов ингавирин и тимоген. Российский биотерапевтический журнал. 2019;18(1):60-6 [Sokolova TM, Poloskov VV, Shuvalov AN, et al. Signaling TLR/RLR-mechanisms of immunomodulating action of ingavirin and thymogen preparations. Russian Journal of Biotherapy. 2019;18(1):60-6 (in Russian)]. doi: 10.17650/1726-9784-2019-18-1-60-66
- Boggu P, Venkateswararao E, Manickam M, et al. Exploration of 2-benzylbenzimidazole scaffold as novel inhibitor of NF-κB. Bioorganic & Medicinal Chemistry. 2016;24(8):1872-88. doi: 10.1016/j.bmc.2016.03.012
- Bowie AG, O’Neill LAJ. Vitamin C Inhibits NF-κB Activation by TNF Via the Activation of p38 Mitogen-Activated Protein Kinase. The Journal of Immunology. 2014;165(12):7180-18. doi: 10.4049/jimmunol.165.12.7180
- Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9(11):1211. doi: 10.3390/nu9111211
- Zhang ZW, Xu XC, Liu T, Yuan S. Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases. Oxid Med Cell Longev. 2016;2016:6859523. doi: 10.1155/2016/6859523
- Смирнов В.С., Петленко С.В., Краснов А.А. «Цитовир® -3». Научное досье. Версия 1.0 от 14.06.2024. [Smirnov VS, Petlenko SV, Krasnov AA. Tsitovir-3. Nauchnoe dos’e. Versiia 1.0 ot 14.06.2024 (in Russian)].
- Клинические исследования. Россия. Цитовир. Режим доступа: https://grlsbase.ru/clinicaltrails/clintrails/?cltr_f=ЦИТОВИ. Ссылка активна на 15.01.2025 [Klinicheskie issledovaniia. Rossiia. Tsitovir. Available at: https://grlsbase.ru/clinicaltrails/clintrails/?cltr_f=TsITOVIR. Accessed: 15.01.2025 (in Russian)].
Supplementary files
